Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Autophagy
    (4)
  • Bcr-Abl
    (4)
  • Apoptosis
    (1)
  • DNA/RNA Synthesis
    (1)
  • Endogenous Metabolite
    (1)
  • Virus Protease
    (1)
  • Others
    (7)
TargetMol | Tags By ResearchField
  • Cancer
    (4)
  • Others
    (1)
Filter
Search Result
Results for "

nilotinib

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    12
    TargetMol | All_Pathways
  • Dye Reagents
    1
    TargetMol | All_Dye_Reagents
  • Isotope Products
    3
    TargetMol | Isotope_Products
  • Reference Standards
    3
    TargetMol | Standard_Products
  • Nilotinib
    Tasigna, AMN107
    T1524641571-10-0
    Nilotinib (AMN107) is a Bcr-Abl tyrosine kinase inhibitor with oral activity. Nilotinib has antitumor activity and may be used for the treatment of Imatinib-resistant chronic myelogenous leukemia (CML).
    • $35
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Nilotinib dihydrochloride dihydrate
    T710681277165-20-4
    Nilotinib dihydrochloride dihydrate is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.
    • $1,520
    4-6 weeks
    Size
    QTY
  • Nilotinib monohydrochloride monohydrate
    Nilotinib (monohydrochloride monohydrate), AMN107 (monohydrochloride monohydrate)
    T2147923288-90-8
    Nilotinib monohydrochloride monohydrate (Nilotinib (monohydrochloride monohydrate)) is significantly potent BCR-ABL against, is a second generation tyrosine kinase inhibitor (TKI), and is active against many BCR-ABL mutants.
    • $30
    In Stock
    Size
    QTY
  • Nilotinib-D6
    AMN107 D6
    T122241268356-17-7
    Nilotinib-D6 is a deuterium labeled Nilotinib (T1524) which is an orally available inhibitor of Bcr-Abl tyrosine kinase ,and with antineoplastic activity.
    • $395
    35 days
    Size
    QTY
  • Nilotinib hydrochloride dihydrate
    T68338923289-71-8
    Nilotinib hydrochloride dihydrate is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.
    • $1,520
    1-2 weeks
    Size
    QTY
  • Nilotinib N-oxide
    T711441246817-85-5
    Nilotinib N-oxide is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.
    • $1,520
    6-8 weeks
    Size
    QTY
  • Nilotinib-D6 (Standard)
    Nilotinib-[D6] (Standard)
    TMSM-64481268356-17-7
    Nilotinib-D6 (Standard) is a reference standard of Nilotinib-D6 intended for quantitative analysis, quality control, and related biochemical research applications.
    • $589
    7-10 days
    Size
    QTY
  • Nilotinib hydrochloride
    AMN-107 HCl
    T22378923288-95-3
    Nilotinib hydrochloride(AMN-107 HCl) is an orally available Bcr-Abl tyrosine kinase inhibitor with antitumor activity for modulation of neuroinflammation and cognitive deficits, and may be used in studies of chronic myelogenous leukemia.
    • $40
    In Stock
    Size
    QTY
  • Nilotinib (Standard)
    TMSM-3451641571-10-0
    Nilotinib (Standard) is a reference standard for research and analysis in studies involving Nilotinib. Nilotinib (AMN107) is a Bcr-Abl tyrosine kinase inhibitor with oral activity. Nilotinib has antitumor activity and may be used for the treatment of Imatinib-resistant chronic myelogenous leukemia (CML).
    • $179
    7-10 days
    Size
    QTY
  • Nilotinib-[13C,D3] (Standard)
    TMSM-52921261398-62-2
    Nilotinib-[13C,D3] (Standard) is a reference standard of Nilotinib-[13C,D3] intended for quantitative analysis, quality control, and related biochemical research applications.
    • $784
    4-6 weeks
    Size
    QTY
  • Cidofovir sodium
    T71066127749-27-3
    Cidofovir sodium is the salt form of Cidofovir, a Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor that is an injectable antiviral medication primarily used as a treatment for cytomegalovirus (CMV) retinitis in people with AIDS. The mechanism of action of cidofovir is as a DNA Polymerase Inhibitor. The chemical classification of cidofovir anhydrous is Nucleoside Analog.
    • $1,520
    1-2 weeks
    Size
    QTY
  • SGX393
    T715811030610-86-6
    SGX393 is an inhibitor of the CML mutant Bcr-AblT315I, thereby preempting in vitro resistance when combined with nilotinib or dasatinib.
    • $1,520
    6-8 weeks
    Size
    QTY